Open access · US-GOV via ClinicalTrials.gov Clinical trial

F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A

Authors not listed

Tammie L. S. Benzinger, MD, PhD · 2014

Loss of proteostasis Human Randomized controlled trial

Abstract

A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2014). F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A. <em>Tammie L. S. Benzinger, MD, PhD</em>. https://clinicaltrials.gov/study/NCT02414347

Vancouver

Anonymous. F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A. Tammie L. S. Benzinger, MD, PhD. 2014.

BibTeX

@misc{anon2014FTTauP, title = {F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A}, author = {Anonymous}, journal = {Tammie L. S. Benzinger, MD, PhD}, year = {2014}, }